Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874504 · ClinicalTrials.gov registry record
Clinical Validation of the Norbert Health Device for Pulse Rate Measurement
A clinical trial, sponsored by Norbert Health.
- Completed
- Registry status
- 40
- Enrollment target
NCT06874504: Completed study, sponsored by Norbert Health.
NCT06874504 is a clinical trial that has completed, run by Norbert Health. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06874504 has completed, sponsored by Norbert Health.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The study will evaluate the measuring pulse rate (PR) using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).
Primary Outcome
To validate the accuracy specification for pulse rate from the ND when compared to an FDA-cleared medical device for heart rate monitoring electrocardiogram (ECG monitor, 5 lead).
Interventions
- DEVICE Norbert Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2025-04-11 |
What the finished NCT06874504 record still lists
NCT06874504 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Norbert Device is the first listed.
NCT06874504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06874504 about?
NCT06874504 is a clinical study titled "Clinical Validation of the Norbert Health Device for Pulse Rate Measurement". The study will evaluate the measuring pulse rate (PR) using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).
What is the current status of trial NCT06874504?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2025-03-13. Estimated completion is 2025-04-11.
What interventions are being tested in trial NCT06874504?
The interventions under investigation include: Norbert Device (DEVICE).
Who is sponsoring clinical trial NCT06874504?
This trial is sponsored by Norbert Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI